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DNA, increased cytokine production and constitutive activation of microglia. Rats lacking ATM had 
significant loss of motor neurons and microgliosis in the spinal cord, consistent with onset of paralysis. 
Betamethasone treatment extended Atm knockout rats' lifespan, prevented microglial activation and 
significantly decreased neuroinflammation and motor neuron loss. These findings provide a basis for 
neurodegeneration in A-T patients and rationale for anti-inflammatory drugs as treatment options for 
A-T patients and more generally in neurodegenerative diseases.  
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Helminths (parasitic worms) can exert protective effects on autoimmune diseases by modulating the 
type of immune response, and deliberate infection with helminths is being explored as a potential 
therapeutic strategy for autoimmunity. However, the use of live helminths as therapeutic agents for 
autoimmune disease has a number of drawbacks, and it would be preferable to instead identify and 
use purified immunomodulatory components of the helminths. Previously it has been shown that the 
immunomodulatory activity of the liver fluke Fasciola hepatica resides in its excretory-secretory 
products (FhES), and further analysis of FhES has identified 3 major components: a 68 amino acid 
alpha helical cathelicidin-like peptide (FhHDM1), a cathepsin L-cysteine protease (FhCL1), and 
peroxiredoxin (FhPrx). In the current study, the ability of these three components to modify the course 
of a relapsing-remitting experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis 
(MS) was tested. FhHDM1 was the most effective, significantly (p< 0.0001) reducing the overall 
severity of the disease and the number of EAE relapses compared to mice treated with vehicle alone 
or mice treated with FhPrx. The effects were long-lasting, with mice continuing to show benefits for up 
to 70 days following a single course of FhHDM1 treatment. Preliminary investigation of the mechanism 
of action of FhHDM1 suggests that it does not affect the adaptive arm of the immune response, but 
instead exerts its effects by modulation of innate pro-inflammatory responses. The data suggest that 
this parasite-derived peptide has potential as a novel therapeutic agent for treatment of MS.  
1675 
Protective roles for microglia in neuroinflammation 
Wlodarczyk, A.1, Holtman, I.R.2, Bruttger, J.3, Yogev, N.3, de Boer-Bergsma, J.J.2, Nolling Jensen, K.1, 
Martin, N.A.4, Karram, K.3, Boddeke, E.W.G.M.2, Waisman, A.3, Eggen, B.J.L.2, Owens, T.1 
1Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark, 2University 
Medical Center Groningen, University of Groningen, Groningen, Netherlands, 3Institute for Molecular 
Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany, 4Institute 
of Clinical Research, Odense University Hospital, Odense, Denmark 
Microglia are central nervous system (CNS)-resident immune cells. They are often referred to as brain 
macrophages and indeed share many phenotypic features with them. However, it is now recognized 
that they are of a separate lineage and are not replaced from blood-derived precursors, at least under 
normal circumstances. Microglia are implicated in neuroinflammatory and neurodegenerative diseases 
including multiple sclerosis (MS). We have shown that in a mouse model for MS- experimental 
autoimmune encephalomyelitis (EAE) numbers of microglia expressing CD11c significantly increase. 
These CD11c+ microglia are effective antigen presenting cells, but poor inducers of Th1 or Th17 
responses. Interestingly, CD11c+ microglia express neuroprotective insulin-like growth factor 1 which 
suggests a neuroprotective rather than proinflammatory role. Here we show that CD11c+ microglia 
predominated in the neonatal brain and expressed genes governing neuronal and glial survival, 
migration and differentiation. These cells were localized in sites of primary myelination such as 
cerebellum and corpus callosum. They expanded rapidly after birth and then contracted to become 
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